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larly into the ischemic limb.
Results: BMA patients had a higher incidence of prior
smoking (90% vs 43%; P < .05) with a trend towards fewer
diabetics (47% vs 71%; P ¼ .07). In the BMA cohort, 84%
had rest pain and 79% had tissue loss. 68% had a prior
bypass or endovascular intervention. Mean follow-up was
334 days (6170). A second BMA treatment was per-
formed in 21% due to clinical deterioration. ABI improve-
ment was 0.23 (60.25). Rest pain improved in 87.5% and
completely resolved in 56%. Wound healing occurred in
67%. 3 patients went on to amputation (Freedom from
major amputation or death at 1.5 years 89% vs 59% (Fig;
P < .05).
Conclusions: Bone marrow aspirate injection therapy
is a potential option in CLI patients who are not candidates
for bypass or endovascular intervention. Limb salvage is
unexpectedly high in this population with few other
options.
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Objectives: Limited evidence exists for management
of acute ﬁnger ischemia (AFI). We evaluated anatomic
ﬁndings, procedural management, and amputation-free
survival in a cohort of patients with AFI.Fig.Methods: Patients undergoing angiography for AFI
were identiﬁed. Data were collected from medical records,
arteriograms, and patient interviews. Outcomes included
anatomic ﬁndings, utilization of thrombolysis, complica-
tions, and amputation-free survival. Descriptive statistics
and survival analysis were used to evaluate results.
Results: 35 patients (Mean age 47.7; 19 women) were
analyzed. Symptom duration was 1-28 days; seven patients
had gangrene. Mean follow-up was 16 months. Baseline
characteristics [n (%)] included: smoking [22 (65)],
connective tissue disease [11 (31)], and repetitive hand
trauma [10 (29)]. Arterial lesions were most frequently
identiﬁed distal to the wrist (n ¼ 32), including 8 ulnar/
radial aneurysms. Proximal lesions were less common (n
¼ 11). Of 23 patients treated with thrombolysis, 11
(47.8%) had interval anatomic improvement. Eleven
patients had subsequent surgical revascularization. Compli-
cations included bleeding (n ¼ 3) and pseudoaneurysm (n
¼ 1). Estimated 1- and 6-month amputation-free survival
(SE) were 0.81 (0.07) and 0.78 (0.07), with no difference
when stratiﬁed by use of thrombolysis.
Conclusions: Angiography performed for AFI
frequently identiﬁes distal occlusive disease, and selective
thrombolysis may expand revascularization options.
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Objectives: Traditionally, thoracic outlet syndrome
(TOS) has been associated with axillo-subclavian vein
stenosis without any mention of the internal jugular (IJ)
vein. However, we recently reported a high prevalence of
IJ stenosis in 109 patients with TOS in a limited study. To
conﬁrm this ﬁnding, we analyzed a bigger cohort of patients.
Methods: We retrospectively analyzed 237 consecu-
tive unique patients referred to our practice with thoracic
outlet syndrome. From April’ 08 to Dec’ 12, all patients
underwent diagnostic brachiocephalic venograms. Avg
age was 49.9 years (r:17 to 81), with 71.8% females and
28.2% male. We looked at the right and left internal jugular
veins and the right and left subclavian veins. Stenoses were
classiﬁed into high (>66%), medium (33%-66%), and low
(<33%). We also looked for presence of collaterals around
the obstructions. Venogram ﬁndings were conﬁrmed by
four investigators independently. For the purposes of this
analysis, high stenosis was considered signiﬁcant.Medium
and low stenoses were considered signiﬁcant only if there
were visible collaterals.
Results: Left internal jugular vein stenosis, left subcla-
vian vein stenosis, right internal jugular vein stenosis, and
right subclavian vein stenosis was seen in 67.5%, 57.6%,
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vein stenosis was not present in 18.1% of patients, present
unilaterally in 33.3% of patients, and present bilaterally in
48.5% of patients. Subclavian vein stenosis was not present
in 24.1% of patients, present unilaterally in 32.5% of
patients, and present bilaterally in 43.5% of patients. Signif-
icant collaterals were present in 26.80% of high stenosis,
21.5% of medium and 12.8% of low.
Conclusions: Internal jugular vein stenosis is common
in patients with thoracic outlet symptoms. Treatment of
internal jugular vein stenosis potentially could beneﬁt these
patients. These ﬁndings could fundamentally change the
diagnosis and treatment of thoracic outlet syndrome.Fur-
ther studies are warranted.
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Objectives: Failure after surgical treatment for neuro-
genic thoracic outlet syndrome (nTOS) is a frustrating
problem for both patients and physicians. Fortunately,
many patients with unresolved or recurrent symptoms
demonstrate a mechanical etiology at operation owing to
inadequate previous rib resection, rib regrowth, or scar
tissue formation. The purpose of this study is to evaluate
the utility of multidetector computed tomography (CT)
in predicting surgical outcomes in patients with recurrent
nTOS.
Methods: A retrospective chart-review was performed
of a TOS referral practice from 2003-2012. In 2003,
a dedicated TOS CT protocol was established to assist in
clinical decision making and operative planning. Imaging
as well as patient clinical characteristics, interventions,
and outcomes were reviewed.
Results: 218 TOS operations were performed on 139
patients. These included 20 reoperations for neurogenic
symptoms. Mean time to failure of primary surgery was
26.6 months, mean follow-up after reoperation was 43.3
months. 60% of redo cases were in females, mean age was
34.8 years. Sixteen procedures involved transaxillary rib
resections with brachial plexus neurolysis (80%). Only 5
(25%) cases involved inadequate previous rib resections;
the remainder for scar tissue (50%) and/or rib regrowth
(40%). There were no neurovascular injuries or complica-
tions other then pneumothorax associated with planned
pleurectomy in ten cases (50%). Nine patients (45%)
demonstrated signiﬁcant improvement or resolution of
symptoms, seven patients (35%) received moderate
improvement in symptoms, and four patients (20%) showed
minimal improvement. Positive-predictive value for the use
of CT in predicting a good surgical outcome was 92.3%.Conclusions: Recurrent thoracic outlet syndrome is
an often vexing problem with challenging solutions. These
results demonstrate the utility of a TOS protocol CT scan
for patient selection and operative planning.
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Objectives: Plasma 25 hydroxycholecaliferol (vit D)
has been associated with adverse cardiovascular outcomes
in epidemiological studies. CKD is associated with loss of
1-a-hydroxylase and vitDdeﬁciency (vitDdef).We hypoth-
esized that vit D def is associated with increased mortality
and decreased vascular access patency in patients undergoing
permanent vascular access for end stage renal disease.
Methods: Case series of 129 patients undergoing
permanent vascular access surgery who also had concurrent
plasma vit D levels. Vit D levels were considered deﬁcient
at <20 ng/mL, insufﬁcient at 21-29, and normal >30
ng/mL. Mortality and vascular access patency were evalu-
ated using multivariate logistic regression models.
Results: The mean age was 66.6, 96.1% were male
and 31.8% African American. 61.2% had diabetes mellitus.
In the entire cohort 75.2% were either insufﬁcient or deﬁ-
cient. Mean follow up time was 2.96 years during which
there were 41 (31.8%) deaths and 79 (64.75%) vascular
access events. Vit D deﬁcient patients tended to be younger
(P ¼ .007), have higher total cholesterol (P ¼ .0002), and
lower calcium levels (P ¼ .031). Despite their younger age,
mortality was signiﬁcantly higher in this group (P ¼ .008)
and AVF patency was worse (P ¼ .015). Age, vit D def,
CAD, HTN, albumin and HgbA1C were associated with
mortality. In multivariate analysis vit D def (OR, 4.26;
CI, 1.37-13.28; P ¼ .012), CAD (OR, 3.56; CI, 1.24-
10.24; P ¼ .018), age (OR, 1.08; CI, 1.03-1.15; P ¼
.002), and albumin (OR, .23; CI, 0.07-0.74; P ¼ .014)
remained signiﬁcant. Vit D deﬁciency (P ¼ .036) and
low hematocrit (P ¼ .011) were independently associated
with a loss of AVF patency.
Conclusions: Vit D deﬁciency is highly prevalent in
patients undergoing vascular access procedures. Patients
who are deﬁcient haveworse survival andmore access related
events. Further study is warranted to assess whether vitamin
D repletion will improve outcomes in this population.
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